The FDA should immediately conduct a review of all generic drug approvals in this class and others to determine what other approvals were made with the same faulty approach of assuming that if one dose worked then the higher dose or lower dose must work the same.

FORBES: A Drug Recall That Should Frighten Us All About The FDA

If there's no exact generic equivalent to the brand-name drug that you are taking, there may be similar drugs in the same class that are close enough.

FORBES: Magazine Article